[
  {
    "ts": null,
    "headline": "Portfolio manager sees long-term AI upside in healthcare sector",
    "summary": "STORY: \"Longer term, we think demographics are definitely there for healthcare,\" said Krawez, who points to the potential of AI to boost productivity in drug development for companies such as Novartis and McKesson.\"One sort of sneaky AI play is within drug development,\" he added. \"There could be a huge boom in productivity.\"",
    "url": "https://finnhub.io/api/news?id=a5b8b90d2ccbf1d9de952a561c4e3eb1406dcdbfb3afa3123e60204d38712e89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752264450,
      "headline": "Portfolio manager sees long-term AI upside in healthcare sector",
      "id": 135883809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "STORY: \"Longer term, we think demographics are definitely there for healthcare,\" said Krawez, who points to the potential of AI to boost productivity in drug development for companies such as Novartis and McKesson.\"One sort of sneaky AI play is within drug development,\" he added. \"There could be a huge boom in productivity.\"",
      "url": "https://finnhub.io/api/news?id=a5b8b90d2ccbf1d9de952a561c4e3eb1406dcdbfb3afa3123e60204d38712e89"
    }
  }
]